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Many chemicals have been released into the
environment without prior evaluation of their
endocrine activity at a molecular level, albeit
the carcinogenic potential of these compounds
is evaluated by routine mutagenicity testing.
However, the concentration necessary to dis-
rupt endocrine regulation may be lower than
the carcinogenic level. Lifelong intake of even
very low levels of these compounds may dis-
turb the delicate hormone balance and com-
promise the reproductive ﬁtness and health of
many species. Likewise, the estrogenic poten-
tial of many environmental contaminants has
been evaluated, but their impact on androgen-
regulated parameters has traditionally been
overlooked. The hormone sensitivity of the
prostate and the rising incidence of prostate
cancer identify it as a possible target organ for
endocrine-disrupting chemicals.
Some environmental contaminants, such
as hexachlorobenzene (HCB), have the
potential to interfere with hormone regula-
tion by mimicking or interfering with natural
hormones. HCB is very persistent in the envi-
ronment and impairs ovarian function in lab-
oratory animals, decreases fertility, and
decreases the weights of both seminal vesicles
and ventral prostates (Elissalde and Clark
1979; Foster et al. 1996; Muller et al. 1978).
In humans, the tissue samples of young boys
with cryptorchidism (undescended testes)
demonstrated elevated HCB levels compared
with control surgical patients (Hosie et al.
2000). These observations of developmental
abnormalities are consistent with those seen
following disruption of hormone regulation. 
Prostate cancer has become the most
commonly diagnosed malignancy and the
second leading cause of cancer-related death
in North American men. However, other
than its correlation to industrialization and
the high incidence of prostate cancer in farm-
ers, very little is known concerning the envi-
ronmental factors that may facilitate the
development of this disease or augment its
progression (Hsing et al. 2000; Sharma-
Wagner et al. 2000; Weston et al. 2000). 
The steroid hormones responsible for
development of the male reproductive tract
are the androgens testosterone and di-
hydrotestosterone (DHT). In speciﬁc tissues,
testosterone is reduced to the more potent,
slower-dissociating androgen DHT (Zhou et
al. 1995). DHT induces development of the
prostate and male external genitalia by bind-
ing to the androgen receptor (AR). The AR is
a member of the nuclear steroid receptor
superfamily and is expressed in prostate cells
and various tissues throughout the body.
Upon androgen binding, it will translocate to
the nucleus to form a homodimer, bind to
androgen-responsive DNA elements, and ini-
tiate the transcription of androgen-regulated
genes (Wong et al. 1995). The AR will bind a
wide variety of ligand structures. In the case of
antiandrogens, such as casodex, binding to the
AR is thought to induce a receptor conforma-
tion that differs from that imposed by agonist
binding, altering its ability to activate tran-
scription (Eckert and Katzenellenbogen 1982;
Hansen and Gorski 1986). Hormone antago-
nists may bind the receptor but prevent DNA
binding and transcriptional activation, or they
may promote receptor and DNA binding but
nevertheless fail to initiate transcription (Truss
and Beato 1993). Activation of the AR by var-
ious polyaromatic hydrocarbons has been
shown to have detrimental effects on the
development and function of the male repro-
ductive system (Gray et al. 1999).
HCB is a known endocrine disruptor
(Gocmen et al. 1989; Smith et al. 1987) that
bioconcentrates in the fat of living organisms.
HCB can persist in the environment for years,
with an estimated half-life in soil of 23 years. It
was used as a fungicide to protect onions,
wheat seed, and other grains. Its production as
an end point has been restricted in North
America since 1971, but it is still formed as a
major by-product in the manufacture of chem-
icals such as solvents, chlorine-containing com-
pounds, and pesticides [Agency for Toxic
Substances and Disease Registry (ATSDR)
1996]. U.S. Environmental Protection Agency
studies have shown that detectable levels of
HCB are found in the tissues of over 95% of
the population (Robinson et al. 1990).
Thousands of people were exposed to HCB in
Kurdistan in eastern Turkey from 1955 to
1961. Retrospective analysis suggests an esti-
mated intake of 2.6–4.1 mg/kg/day (Cripps et
al. 1984; Gocmen et al. 1989).
In this article we demonstrate that HCB
partially agonizes androgen action using a highly
sensitive reporter gene assay. Cotransfection of
the AR and an androgen-regulated luciferase
reporter construct in a well-differentiated
prostate cell line measured the ability of HCB
to inﬂuence AR action. Results from a bind-
ing assay using thioredoxin-fused AR ligand
binding domain demonstrated that HCB did
not influence binding of androgen to its
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Hexachlorobenzene (HCB) is a persistent environmental contaminant that has the potential to
interfere with steroid hormone regulation. The prostate requires precise control by androgens to
regulate its growth and function. To determine if HCB impacts androgen action in the prostate,
we used a number of methods. Our in vitro cell-culture–based assay used a firefly luciferase
reporter gene driven by an androgen-responsive promoter. In the presence of dihydrotestosterone,
low concentrations (0.5–5 nM) of HCB increased the androgen-responsive production of ﬁreﬂy
luciferase and high concentrations of HCB (> 10 µM) suppressed this transcriptional activity.
Results from a binding assay showed no evidence of affinity between HCB and the androgen
receptor. We also tested HCB for in vivo effects using transgenic mice in which the transgene was
a prostate-specific, androgen-responsive promoter upstream of a chloramphenicol acetyl trans-
ferase (CAT) reporter gene. In 4-week-old mice, the proportion of dilated prostate acini, a marker
of sexual maturity, increased in the low HCB dose group and decreased in the high HCB dose
mice. In the 8-week-old mice, there was a signiﬁcant decrease in both CAT activity and prostate
weight upon exposure to 20 mg/kg/day HCB. Therefore, in vitro and in vivo data suggest that
HCB weakly agonizes androgen action, and consequently, low levels of HCB enhanced androgen
action but high levels of HCB interfered. Environmental contaminants have been implicated in
the rising incidence of prostate cancer, and insight into the mechanisms of endocrine disruption
will help to clarify their role. Key words: androgen receptor, hexachlorobenzene, mice, prostate,
steroid hormone. Environ Health Perspect 111:461–466 (2003). doi:10.1289/ehp.5919 available
via http://dx.doi.org/ [Online 9 January 2003]receptor. Our novel and highly sensitive in
vivo approach used two strains of transgenic
mice to test the impact of HCB on hormone
action. The mE-RABP-CAT and LPB-CAT
mouse express the chloramphenicol acetyl
transferase (CAT) reporter gene under the
direction of a highly androgen-sensitive pro-
moter in the epididymis and prostate, respec-
tively (Lareyre et al. 1999, 2000; Yan et al.
1997). HCB decreased CAT expression and
prostate weights in both strains of mice.
Materials and Methods
Plasmids. The full-length rat AR cDNA
cloned into pRc-CMV (Rennie et al. 1993),
rat glucocorticoid receptor (GR) plasmid
(Kasper et al. 1999), and human estrogen
receptor (ER) (Smith et al. 1993) were used in
the transfection-based assay. The luciferase
reporter gene construct responsive to andro-
gens and glucocorticoids (ARR3-luc) consisted
of three rat probasin androgen-response ele-
ments upstream of the ﬁreﬂy luciferase vector
(Snoek et al. 1996). The estrogen-responsive
luciferase reporter gene construct (ERE-luc)
plasmid consisted of a single vitellogenin
estrogen response element cloned into a ﬁreﬂy
luciferase vector (Portigal CL. Unpublished
data). The pRL-tk vector obtained from
Promega (Madison, WI, USA) contained a
thymidine kinase promoter upstream of
renilla luciferase cDNA. The pPSA-luc con-
tains prostate-speciﬁc antigen (PSA) 5´-ﬂank-
ing DNA as described previously (Sato et al.
1997). All plasmid DNA was propagated in
JM109 Escherichia coli and was prepared
using a QIAGEN Maxiprep Kit (QIAGEN,
Mississauga, Ontario, Canada).
Cell culture transfections. HCB (Aldrich
Chemical Company, Milwaukee, WI, USA)
was prepared as a 10-mM stock in ether.
PC3 prostate cancer cells were plated in
Dulbecco’s Modified Eagle’s Medium
(DMEM) (GibcoBRL, Burlington, Ontario,
Canada) supplemented with 5% dextran-
coated charcoal-stripped fetal bovine serum.
Plasmids were transiently transfected into the
cells using Lipofectin Reagent (GibcoBRL).
Each plate received 1.5 µg of the AR, ER, or
GR plasmid, 1 µg of the corresponding
reporter construct (ARR3-luc or ERE-luc),
and 0.01 µg of pRL-tk. HCB and the appro-
priate hormone (2.5 nM DHT, 1 nM dexam-
ethasone (DEX), or 1 nM estradiol) were
added after a 6-hr incubation. Cells were har-
vested 24 hr later and lysed using Passive Lysis
Buffer (Promega). Luciferase assays were per-
formed using the Dual-Luciferase Reporter
Assay System (Promega) and the EG&G
Berthold Microplate Luminometer LB 96V
(Berthold Technologies, Bad Wildbad,
Germany). The transfection experiments were
also repeated in a similar manner using
LNCaP prostate cancer cells cultured in RPMI
1640 deﬁned medium (GibcoBRL). The cyto-
toxicity of HCB was assessed by staining sam-
ples with trypan blue and counting viable cells.
Cell culture ligand displacement assay.
Recombinant rat thioredoxin-fused AR ligand
binding domain (Trx-ARLBD) was obtained
from PanVera (Madison, WI, USA) and
diluted in binding buffer (50 mM Tris pH 7.5,
10% glycerol, 0.8 M NaCl, 1 mg/mL BSA,
and 2 mM dithiothreitol). A stock of assay mix
was prepared by combining 20 nM 3H-R1881
(NEN Life Science Products, Inc., Boston,
MA, USA) and 2% ethanol in binding buffer.
A range of test compound concentrations was
added to the diluted Trx-ARLBD and assay
mix. After overnight incubation at 4°C, we
added 33% hydroxylapatite (HAP) slurry [Fast
Flow Hydroxylapatite (Calbiochem, San
Diego, CA, USA) in 10 mM Tris pH 8.0 and
1 mM EDTA]. The HAP pellets were incu-
bated on ice for 10 min, then washed three
times with wash buffer (40 mM Tris pH 7.5,
100 mM KCl, 1 mM EDTA, and 1 mM
EGTA). The HAP pellet was resuspended in
ethanol and transferred to a scintillation vial.
Scintillation counting was completed using the
Beckman LS 6500 scintillation counter
(Beckman, Mississauga, Ontario, Canada), and
results were expressed as mean ± SEM.
In vivo experiments. All animal studies
were conducted in accordance with the princi-
ples and procedures outlined by the Canadian
Council on Animal Care and approved by
institutional ethics committees. Animals were
kept in standard conditions in 12-hr light:12-
hr dark cycles in the animal care facilities in the
Jack Bell Research Centre (Vancouver, British
Columbia, Canada). The mice were fed a stan-
dard laboratory mouse chow and water ad
libitum. The doses used in the experiment
were chosen after a review of relevant litera-
ture (Cripps et al. 1984; Geyer et al. 1986;
Gocmen et al. 1989). We tried to approxi-
mate human exposure while factoring in dif-
ferences in the size, bioconcentration factors,
and life span of mice. Bioconcentration fac-
tors (wet weight basis) of chemicals are
between 3 and 47 times higher in humans
than rats (Geyer et al. 1986).
The mice used in the first study were
CD1 strain homozygous transgenic for an
androgen-sensitive reporter gene. This con-
sisted of a large section of the 5´-flanking
sequence of the rat probasin gene linked to
the bacterial CAT reporter gene (designated
LPB-CAT). The transgene has been shown to
be androgen sensitive and prostate specific
(Yan et al. 1997). Five female mice were used
in each of the five dose groups. All were fed
0.1 mL canola oil per day. The doses were as
follows: control, canola oil alone; positive con-
trol, 0.1 mg/kg/day testosterone undecanoate
in canola oil; low dose, 5 mg/kg/day HCB in
canola oil; medium dose, 10 mg/kg/day; and
high dose, 20 mg/kg/day HCB in canola oil.
Females were dosed for a minimum of 1
month and then paired with males, one pair
per cage. The exception is the testosterone-
dosed dams, which could only be treated after
conception; prepregnancy treatment with
testosterone led to transient infertility. The
dams were dosed throughout gestation
(3 weeks) and lactation (3 weeks) until wean-
ing. Male offspring were then treated for an
additional 1 or 5 weeks until they reached 4 or
8 weeks of age, respectively.
In the second study we used a mouse strain
designated mE-RABP-CAT. The epididymis
of this transgenic mouse strain synthesizes a
CAT reporter gene upstream of a retinoic
acid-binding protein promoter (mE-RABP).
The gene is specifically expressed in mouse
mid/distal caput epididymis under the control
of androgen (Lareyre et al. 1999, 2000). Seven
females were dosed with 0.1 mL/day corn oil,
and seven females were dosed with 10
mg/kg/day HCB in corn oil. The mice were
paired and dosed as described above. 
Treated male mice were sacriﬁced by car-
diac exsanguination under methoxyfluorane
anesthesia. Anogenital distance (AGD) and
body weights were measured. The liver, left
testis, left epididymis, and ventral prostate were
removed, weighed and frozen. The ventral
prostate and liver were first subdivided; half
were frozen and the other half were fixed in
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Figure 1. Impact of increasing compound levels on
firefly luciferase production in PC3 cells. (A) Cells
transfected with AR, ARR3-luc, and pRL-tk and
incubated in the presence of DHT. (B) Cells trans-
fected with the appropriate DNA constructs and
incubated in the presence of half-maximal hormone
levels and a range of HCB concentrations. An aver-
age of at least three experimental determinations,
with three replicates each, were performed. Fireﬂy
luciferase values were normalized for transfection
efficiency using activity of renilla luciferase as
baseline levels. Data points indicate mean values;
error bars indicate SEM. 
*Signiﬁcantly different from the control (p < 0.01).
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×10% neutral buffered formalin for histologic
analysis. The right testis, right epididymis, and
heart were also fixed for histologic examina-
tion. Serum testosterone and thyroxine (T4)
levels were tested. Blood from each animal was
allowed to clot at room temperature for at least
15 min, and serum was obtained by centrifuga-
tion at 14,000 × g for 10 min. Serum was then
immediately frozen at –20°C until it was
examined for serum testosterone (Tumor
Marker Lab, British Columbia Cancer Agency,
Vancouver, British Columbia, Canada) and
thyroid hormone levels (T4 ELISA kit;
Monobind, Costa Mesa, CA, USA). For the
CAT assay, the organ of interest was homoge-
nized and lysed. The protein level was mea-
sured using a Pierce BCA assay (Pierce
Biotechnology, Rockford, Il, USA). One gram
of protein in lysis buffer was heated to 65°C
and added to a chloramphenicol, Tris, and
3H-acetyl coenzyme A (CoA) solution.
ScintiLene scintillation ﬂuid (Fisher Scientiﬁc,
Nepean, Ontario, Canada) was layered on top,
and then scintillation counts were taken over
time. The slope of disintegrations per minute
over time corresponds to CAT activity.
Histopathologic analysis. Slides containing
sections of prostate, liver, heart, or epididymis
were stained with hematoxylin-eosin. The same
pathologist examined each section in a ran-
domized manner using a photonic microscope.
Statistical analysis. All data sets were
tested for uniform distribution. Statistical sig-
niﬁcance (p = 0.05) among the various para-
meters assessed was established by a Student’s
t-test when a single treatment was compared
with the control or by analysis of variance
when the comparison was between several
groups. Upon demonstration of statistical sig-
niﬁcance, Dunnett’s multiple comparison test
indicated which groups were signiﬁcantly dif-
ferent from the control group. Statistical
analyses were performed using JMP statistical
software (SAS Institute, Cary, NC, USA).
Results
Hexachlorobenzene modulates androgen
activity in vitro. Based on the observation that
HCB is highly persistent and has the potential
to interfere with hormone regulation, we
wanted to test if HCB would mimic or inhibit
steroid hormones important in the prostate
using a tissue cell-culture–based assay. Our
approach used DNA constructs containing
hormone-responsive binding sites connected to
a ﬁreﬂy luciferase reporter gene. The amount
of luciferase produced was proportional to the
degree of transcriptional activity induced by
the ligand-bound receptor. The pRL-tk was
cotransfected as a transfection control and was
constitutively expressed.
Increasing concentrations of DHT, a posi-
tive control, induced rising firefly luciferase
production in PC3 cells transfected with the
ARR3-luc reporter plasmid and the full-length
rat AR (Figure 1A). After this standardization
of our assay, we asessed the impact of HCB. In
the presence of half-maximal DHT, low levels
of HCB enhanced the androgen-responsive
transcription of the luciferase reporter gene up
to 2-fold higher than DHT alone. High levels
of HCB suppressed this androgen-mediated
activity (Figure 1B). This HCB-induced modi-
ﬁcation of transcriptional activity was depen-
dent upon the presence of the AR (data not
shown), and it appeared to be speciﬁc to the
AR. In the presence of GR or ER and their
respective hormones, HCB did not interfere
with hormone-inducible transcription
(Figure 1B). These experiments were repeated
in two different prostate cell lines, PC3 and
LNCaP, with different promoters (ERE-luc,
ARR3-luc, and PSA-luc). The same trend was
seen in both cell lines regardless of whether
PSA-luc or ARR3-luc was used. In LNCaP
cells, HCB will act to agonize androgen action
in the presence of the endogenous mutated
AR, but this impact is insigniﬁcant when com-
pared with the response elicited by the trans-
fected receptors. Each set of test conditions was
reproduced in triplicate, and each experiment
was repeated a minimum of three times. Based
on our observations that HCB impacts in vitro
AR action specifically, the next step was to
determine if HCB binds directly to the AR. 
Hexachlorobenzene was not an AR ligand
in vitro. Tritiated R1881, a synthetic andro-
gen, was added to AR ligand binding domain.
Nonradioactive ligand (DHT, DEX, or
HCB) was added and displaced the tritiated
R1881 if the afﬁnity was greater. The pellets
were washed and assessed for levels of radioac-
tivity. If binding to the AR occurred, there
was a decrease in scintillation counts. Results
from this assay indicated that the DHT con-
trol was a ligand of the AR, but HCB and
DEX were not (Figure 2).
Hexachlorobenzene alters androgen-
responsive parameters in vivo. Male mice were
treated throughout gestation and lactation via
maternal exposure. Three weeks after the date
of birth, the male offspring were weaned and
fed individually for an additional 1 or 5 weeks
to correspond to a sacrifice age of 4 or 8
weeks, respectively. Two different sacrifice
points were used because some effects such as
delayed or precocious puberty are seen at the
immature/prepubescent time point of 4 weeks
of age. Other effects can only be observed
when the animal is mature, such as abnormal
development, or upon sufﬁcient accumulation
of the chemical to produce detectable effects. 
High-dose HCB decreased CAT activity in
adult LPB-CAT male mice. CAT reporter
activity in the LPB-CAT mice corresponded to
the degree of androgen activity in the prostate
(Figure 3). In the 4-week-old mice, the andro-
gen-responsive CAT activity of the testos-
terone-dosed mice was signiﬁcantly higher (p <
0.01). In the 8-week-old mice, the CAT activ-
ity of mice treated with the medium and high
HCB dose was signiﬁcantly (p < 0.05) lower.
We used a second strain of mice to confirm
that the observations were not unique to the
LPB-CAT mice. mE-RABP-CAT mice also
expressed an androgen-responsive CAT
reporter. However, several differences exist: the
promoter was based on a fragment from the
epididymal retinoic acid-binding protein rather
than the probasin gene, the transgene was
expressed speciﬁcally in the epididymis rather
than the prostate, and these mice have a
C57BL/6 rather than a CD1 background. No
significant change in CAT activity was
observed between the 10 mg/kg/day HCB-
treated and control mice at 4 weeks of age, but
there was a significant (p =0.05) decrease in
androgen-responsive epididymis-speciﬁc CAT
activity of 8-week-old mice dosed with 10
mg/kg/day HCB compared with controls
(Figure 4). Thus, it was demonstrated that
HCB could impact androgen-regulated tran-
scriptional activity in both strains of mice.
The weight of the prostate is also a measure
of androgen activity. The prostate is responsive
to androgen levels, as treatment with antian-
drogens or castration will decrease the prostate
weight (Iguer-Ouada and Verstegen 1997;
Schroder 1994). Administration of exogenous
testosterone to immature males accelerates
prostatic growth so that maximal prostatic
size is achieved precociously (Cunha et al.
1987). Prostate development is induced by
DHT, and although we used an oral form of
testosterone (testosterone undecanoate), its
conversion to DHT has been reported (Horst
and Erdmann 1980). The average prostate
weight of 4-week-old LPB-CAT mice treated
with either testosterone or the low dose of
HCB was significantly higher than the aver-
age for the controls (Figure 5). In the 8-week-
old LPB-CAT mice, treatment with the high
dose of HCB signiﬁcantly lowered the average
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Figure 2. Effects of nontritiated potential ligand
added to thioredoxin-fused AR ligand binding
domain (Trx-AR-LBD). Trx-AR-LBD aliquots were
incubated in the presence of 20 nM 3H-R1881, and
then DHT or HCB or DEX was added. DHT dis-
placed R1881 and bound the AR, whereas DEX and
HCB did not.
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■prostate weight compared with the control
average (p < 0.01). A decrease in prostate
weight implied a delay in sexual maturity and
was previously observed following exposure to
vinclozolin (Gray et al. 1994), genistein
(Delclos et al. 2001), or soy phytoestrogens
(Weber et al. 2001). Prostatic acini convert
from a nondilated to a dilated form around
the time of puberty and could therefore be
used as a marker of sexual maturity. Exposure
to the low dose of HCB in 4-week-old mice
caused a signiﬁcant increase in the percentage
of cases where dilated prostate acini are
observed. However, dilated prostatic acini
were not observed in any of the high HCB
dose samples. Dilated acini were observed in
every 8-week-old mouse prostate (Figure 6).
These data suggest that HCB agonized andro-
gen action at low doses, but antagonized it at
high concentrations.
Other androgen-sensitive organs include
the epididymis and the testis; AGD is also
affected by androgen. Treatment with testos-
terone, low-dose HCB, and medium-dose
HCB in the 4-week-old (Table 1) and low-
dose HCB in the 8-week-old LPB-CAT
(Table 2) males induced a higher average epi-
didymis weight. Thus, low-dose HCB treat-
ment increased the weight of the epididymis,
an androgen-sensitive organ, at both time
points. Exposure to testosterone propionate
(Orgebin-Crist et al. 1983) increases the
weight of the epididymis, whereas ethinyl-
estradiol (Kinomoto et al. 2000) or ﬂutamide
(Toyoda et al. 2000) exposure decreases it. The
AGD is a developmental marker and is larger
in males than females. In this study, the
medium dose of HCB signiﬁcantly increased
the average AGD compared with the control
group (Table 2). Exposure to antiandrogens
has been shown to decrease the AGD (Gray
et al. 2001; Hib and Ponzio 1995; McIntyre et
al. 2001). In 4-week-old LPB-CAT mice
(Table 1), average testis weights of the mice
treated with testosterone or the low-dose HCB
were signiﬁcantly higher than the control (p <
0.05). In the current study, the impact of HCB
on the testes was not as pronounced as other
organs of the male reproductive tract. This may
have been because the mammalian testis accu-
mulates lower levels of organochlorine chemi-
cals compared with other tissues and affords the
germ cells some protection from the potentially
toxic compounds (Cooke et al. 2001).
The serum testosterone levels of both the
4-week-old and 8-week-old LPB-CAT mice
were measured by the British Columbia
Cancer Agency Tumor Marker Lab; because
of the temporal nature of hormone release,
the values were highly variable. No statisti-
cally significant changes were observed, but
the average testosterone level of the 4-week-
old testosterone-dosed mice was about 3–4
times higher than the control average (data
not shown). In a previous study, mice dosed
with 250 mg HCB/kg for 21 days demon-
strated an increase in vitro metabolism of
[3H] testosterone, a decrease in serum con-
centrations of testosterone, and a decrease in
weights of seminal vesicles and ventral
prostates (Elissalde and Clark 1979).
The T4 thyroid hormone levels of 4- and
8-week-old mice were tested, and no visible
or statistically significant changes or trends
were observed (data not shown). Thyroid
hormone levels were tested, as previous stud-
ies showed that HCB induced hypothy-
roidism, albeit at higher doses (Foster et al.
1993; van Raaij et al. 1994).
Acute toxicity was not observed. Chronic
ingestion of HCB is associated with hepato-
megaly, loss of body weight, wasting of skele-
tal muscles, leukocytosis, and enlarged thyroid
(Hayes and Laws 1991). We measured heart,
liver, and body weight to assess signs of toxic-
ity in the treated mice. In this study, we stud-
ied endocrine-speciﬁc effects and attempted to
keep the exposure levels below those that are
overly toxic. Loss of body weight was not
observed in test mice upon exposure to
HCB. The average body weight was signifi-
cantly (p < 0.01) higher in the groups treated
with the low and medium doses of HCB
(Tables 1 and 2). The average liver weights
significantly increased upon exposure to
HCB, but lesions were not observed (Tables
1 and 2). The increase in liver weight may
have been due to altered glycogen storage, as
there was a dose-dependent increase in cen-
trilobular hepatocellular vacuolization (data
not shown). Multifocal hepatic necrosis and
mild inflammation of periportal spaces were
observed in a few of the samples (data not
shown). These alterations are common and
were not associated with a speciﬁc treatment
group. Therefore, although the livers of the
high-dose HCB group were enlarged and
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Figure 6. Percentage of cases in which the presence
of dilated acini was observed in the prostates of
LPB-CAT mice at 4 weeks of age (prepubescent) and
8 weeks of age (sexually mature). Abbreviations: C,
control; H, high-dose HCB; L, low-dose HCB; M,
medium-dose HCB; T, testosterone. Progression
from nondilated to dilated acini was a marker for
sexual maturity. 
*Signiﬁcantly different from the control (p < 0.05).
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Figure 4. Effects of HCB in mE-RABP-CAT mice
dosed until sacriﬁce at 4 weeks of age (prepubes-
cent) or 8 weeks of age (sexually mature). There was
a signiﬁcant decrease in CAT activity at 8 weeks of
age in response to treatment with 10 mg/kg/day com-
pared with controls dosed with vehicle alone. 
*Signiﬁcantly different from the control (p = 0.05).
Figure 5. Effects of HCB or testosterone in LPB-CAT
mice dosed until sacrifice at 4 weeks of age (pre-
puberty) or 8 weeks of age (sexually mature).
Abbreviations: C, control; H, high-dose HCB; L, low-
dose HCB; M, medium-dose HCB; T, testosterone.
The androgen-sensitive prostate weight increased
in the low-dose HCB-treated immature mice but
decreased in response to the high HCB dose in
sexually mature animals. 
**Signiﬁcantly different from the control (p < 0.01).
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Figure 3. Androgen-responsive CAT activity in LPB-
CAT mice increased in 4-week-old mice (prepubes-
cent) treated with testosterone and decreased in
8-week-old mice (sexually mature) treated with HCB.
Abbreviations: C, control; H, high-dose HCB; L, low-
dose HCB; M, medium-dose HCB; T, testosterone.
*Significantly different from the control (p < 0.05).
**Signiﬁcantly different from the control (p < 0.01).
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8 Weeksslightly altered glycogen storage was observed,
no severe liver toxicity was linked with the
doses of HCB used. Heart weight was
increased in the highest HCB dose group
(Tables 1 and 2). The hearts examined had a
normal histological architecture and no lesion
was detected in the sections (data not shown). 
Discussion
The endocrine system acts as a communica-
tion network, and the signals are transmitted
via hormones. The levels of individual hor-
mones are tightly controlled for effective
endocrine regulation and production of the
appropriate biological response at the desired
time. Endocrine disruptors are compounds
that are able to mimic or block this natural
biological process. Because of a certain degree
of promiscuity of steroid hormone receptors,
they are able to bind a variety of distinct mol-
ecules, albeit with different binding afﬁnities.
The endocrine and reproductive effects of envi-
ronmental contaminants are believed to result
from a) mimicking endogenous hormones
such as estrogens and androgens, b) antagoniz-
ing normal endogenous hormones, c) altering
the pattern of synthesis and metabolism of nat-
ural hormones, d) modifying hormone recep-
tor levels, or e) interfering with steroid-binding
protein or steroid transport. Many of the
endocrine-disruptor studies have traditionally
focused on the impact of environmental estro-
gens. Novel data have emerged that demon-
strate the impact of endocrine disruptors on
the androgen axis.
Vinclozolin and p,p´-DDE [1,1,1-trichloro-
2,2-bis(p-chlorophenyl)ethylene] act as AR
ligands and antagonize transcriptional activity
in vitro. Exposure to p,p´-DDE and vinclo-
zolin causes malformations of the male repro-
ductive tract in neonates, including a decrease
in prostate weights, suppression of androgen-
regulated genes, reduced AGD, retained nip-
ples, and reduced ventral prostate weights
(Gray et al. 1994; Kelce et al. 1997). Although
it is not an AR ligand, similar results are seen
upon exposure to TCDD (2,3,7,8-tetra-
chlorodibenzo-p-dioxin) (Mably et al. 1992).
Compounds such as HCB and TCDD may
inﬂuence androgen action via the aryl hydro-
carbon receptor (AhR). The AhR is expressed
in prostate epithelial cells, and stimulation of
the AhR by various polyaromatic hydrocar-
bons has detrimental effects on the male
reproductive system. The AR is also expressed
in prostate cells, and crosstalk between the AR
and AhR has been shown in vitro. TCDD is
the most potent inducer of AhR activity.
Testosterone inhibited TCDD-induced
CYP1A1 activity in a dose-dependent manner.
Reciprocally, testosterone-dependent tran-
scriptional activity and testosterone-regulated
PSA expression in the prostate cell line
LNCaP was inhibited by TCDD (Jana et al.
1999). Ligand-independent activation of the
AR via the estrogen-induced growth factor
pathway has also been demonstrated in
prostate organ culture (Gupta 2000). In some
circumstances, crosstalk may be a normal part
of signaling in the prostate, but inappropriate
activation or suppression will disrupt the func-
tion of the cell and organ development.
HCB was introduced in 1945 as a fungi-
cide that interferes with amine and thiol
metabolism to slow the growth rate and
sporulation of fungi. It is still formed as a
major by-product and contaminant in the
manufacture of chemicals such as solvents,
chlorine-containing compounds, and pesti-
cides (ATSDR 1996). Total daily intake from
air, food, and soil by adults in the general
North American population is about 3
ng/kg/day (Newhook and Meek 1994).
Average intake of HCB by breast-feeding
infants in the general population is much
higher (Uhnak and Szokolay 1983), and lacta-
tional transfer of HCB has been demonstrated
(Nakashima et al. 1997). Childhood exposure
to HCB may inﬂuence reproduction or physi-
cal and mental development. A previous study
demonstrated elevated levels of HCB in young
males with undescended testes (Hosie et al.
2000). HCB has a potent capacity for accu-
mulation from the environment into the fatty
tissues of living organisms (Ernst 1986; Hayes
and Laws 1991). Many of the environmental
contaminants are lipophilic, and androgens
have been shown to stimulate the accumula-
tion of lipids in LNCaP prostate cancer cells
(Swinnen et al. 1996). Environmental conta-
minants have been implicated in the rising
incidence of prostate cancer, and insight into
the mechanisms of endocrine disruption will
help to clarify their role. 
In this study, mice were orally dosed with
HCB levels similar to highly exposed individ-
uals, but elevated compared with average
human exposure levels. At low doses, HCB
acted as an androgen agonist in vitro and in
vivo. It increased the production of the andro-
gen responsive reporters, firefly luciferase in
PC3 cells, and the presence of dilated acini in
the prostates of sexually immature LPB-CAT
mice. However, higher doses of HCB appar-
ently antagonized androgen action, as the pro-
duction of ﬁreﬂy luciferase was reduced. HCB
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Table 1. Mean (SEM) organ weights and AGD of 4-week-old LPB-CAT mice treated with canola oil,
testosterone, or HCB. 
Control Testosterone Low HCB Medium HCB High HCB
Organ (n = 11) (n = 9) (n = 6) (n = 8) (n = 5)
Prostate (g) 0.0051 0.0071** 0.0077** 0.0060 0.0038
(0.0006) (0.0005) (0.0004) (0.0006) (0.0005)
Testis (g) 0.0596 0.0700* 0.0702* 0.0645 0.0600
(0.0012) (0.0036) (0.0034) (0.0023) (0.0041)
Epididymis (g) 0.0114 0.0151** 0.0145** 0.0134** 0.0106
(0.0005) (0.0003) (0.0002) (0.0005) (0.0011)
AGD (mm) 8.43 9.11 8.53 9.51 9.17
(0.25) (0.35) (0.52) (0.36) (0.25)
Body weight (g) 20.45 23.65** 25.81** 23.90** 20.31
(0.60) (0.80) (0.71) (0.49) (1.06)
Liver (g) 1.037 1.297** 1.257** 1.299** 1.222**
(0.046) (0.024) (0.072) (0.035) (0.060)
Heart (g) 0.105 0.132** 0.136** 0.131** 0.122**
(0.004) (0.005) (0.004) (0.003) (0.006)
*Signiﬁcantly different from the control (p < 0.05). **Signiﬁcantly different from the control (p < 0.01).
Table 2. Mean (SEM) organ weights and AGD of 8-week-old LPB-CAT mice treated with canola oil,
testosterone, or HCB.
Control Testosterone Low HCB Medium HCB High HCB
Organ (n = 10) (n = 9) (n = 6) (n = 8) (n = 5)
Prostate (g) 0.0148 0.0127 0.0150 0.0156 0.0112**
(0.0006) (0.0008) (0.0009) (0.0009) (0.0010)
Testis (g) 0.1271 0.1339 0.1342 0.1241 0.1264
(0.0033) (0.0046) (0.0032) (0.0083) (0.0051)
Epididymis (g) 0.0276 0.0306 0.0323* 0.0280 0.0268
(0.0009) (0.0012) (0.0009) (0.0011) (0.0020)
AGD (mm) 12.17 11.54 11.21 13.45** 11.90
(0.55) (0.30) (0.26) (0.22) (0.72)
Body weight (g) 27.99 29.43 32.72** 31.89** 29.12
(0.79) (0.67) (0.98) (0.50) (0.97)
Liver (g) 1.327 1.482 1.549 1.733** 1.848**
(0.043) (0.069) (0.073) (0.062) (0.070)
Heart (g) 0.148 0.162 0.168* 0.162 0.172*
(0.004) (0.006) (0.005) (0.006) (0.009)
*Signiﬁcantly different from the control (p < 0.05). **Signiﬁcantly different from the control (p < 0.01).did bind directly to the AR and may inﬂuence
androgen action by altering steroid transport
or via receptor crosstalk. In LPB-CAT mice,
the high dose of HCB downregulated CAT
activity in 8-week-old mice, decreased the
presence of dilated prostatic acini, and lowered
the average prostate weight. In mE-RABP-
CAT mice, HCB decreased the CAT activity
of 8-week-old mice. 
These data provide conclusive evidence of
HCB acting as an endocrine disruptor in mice
and demonstrates its potential to impact the
human androgen axis. HCB can interfere with
the transcriptional activity of androgen-regu-
lated genes and the downstream effects, thus
amplifying its potential endocrine-disrupting
impact. The fact that HCB may affect the
androgen-signaling pathway in a different
manner depending on the dose should rein-
force the concept that environmental xeno-
biotics, though present at low doses, may pose
a threat to human health.
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